Literature DB >> 17640961

The role of complement in inflammatory diseases from behind the scenes into the spotlight.

Maciej M Markiewski1, John D Lambris.   

Abstract

Our understanding of the biology of the complement system has undergone a drastic metamorphosis since its original discovery. This system, which was traditionally primarily described as a "complement" to humoral immunity, is now perceived as a central constituent of innate immunity, defending the host against pathogens, coordinating various events during inflammation, and bridging innate and adaptive immune responses. Complement is an assembly of proteins found in the blood and body fluids and on cell surfaces. Soluble complement components form the proteolytic cascade, whose activation leads to the generation of complement effectors that target various cells involved in the immune response. Membrane-bound receptors and regulators transmit signals from complement effectors to target cells and limit complement activation to the surfaces of pathogens and damaged or activated host cells. The multiple interconnections among complement proteins, immune cells, and mediators provide an excellent mechanism to protect the organism against infections and support the repair of damaged tissues. However, disturbances in this "defense machinery" contribute to the pathogenesis of various diseases. The role of complement in various inflammatory disorders is multifaceted; for example, the activation of complement can significantly contribute to inflammation-mediated tissue damage, whereas inherited or acquired complement deficiencies highly favor the development of autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17640961      PMCID: PMC1959484          DOI: 10.2353/ajpath.2007.070166

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  84 in total

1.  Regulation of IL-6 synthesis in human peripheral blood mononuclear cells by C3a and C3a(desArg).

Authors:  W H Fischer; M A Jagels; T E Hugli
Journal:  J Immunol       Date:  1999-01-01       Impact factor: 5.422

2.  Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies.

Authors:  M Botto; C Dell'Agnola; A E Bygrave; E M Thompson; H T Cook; F Petry; M Loos; P P Pandolfi; M J Walport
Journal:  Nat Genet       Date:  1998-05       Impact factor: 38.330

3.  C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes: complement deficiency and systemic lupus erythematosus revisited.

Authors:  L C Korb; J M Ahearn
Journal:  J Immunol       Date:  1997-05-15       Impact factor: 5.422

Review 4.  TNF, immunity and inflammatory disease: lessons of the past decade.

Authors:  B Beutler
Journal:  J Investig Med       Date:  1995-06       Impact factor: 2.895

5.  Requirement and role of C5a in acute lung inflammatory injury in rats.

Authors:  M S Mulligan; E Schmid; B Beck-Schimmer; G O Till; H P Friedl; R B Brauer; T E Hugli; M Miyasaka; R L Warner; K J Johnson; P A Ward
Journal:  J Clin Invest       Date:  1996-07-15       Impact factor: 14.808

6.  Human complement factor H deficiency associated with hemolytic uremic syndrome.

Authors:  N Rougier; M D Kazatchkine; J P Rougier; V Fremeaux-Bacchi; J Blouin; G Deschenes; B Soto; V Baudouin; B Pautard; W Proesmans; E Weiss; L Weiss
Journal:  J Am Soc Nephrol       Date:  1998-12       Impact factor: 10.121

7.  A critical role for complement in maintenance of self-tolerance.

Authors:  A P Prodeus; S Goerg; L M Shen; O O Pozdnyakova; L Chu; E M Alicot; C C Goodnow; M C Carroll
Journal:  Immunity       Date:  1998-11       Impact factor: 31.745

8.  Mannose-binding protein gene polymorphism in systemic lupus erythematosus.

Authors:  E J Davies; N Snowden; M C Hillarby; D Carthy; D M Grennan; W Thomson; W E Ollier
Journal:  Arthritis Rheum       Date:  1995-01

9.  Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus.

Authors:  M Herrmann; R E Voll; O M Zoller; M Hagenhofer; B B Ponner; J R Kalden
Journal:  Arthritis Rheum       Date:  1998-07

10.  Complement-dependent clearance of apoptotic cells by human macrophages.

Authors:  D Mevorach; J O Mascarenhas; D Gershov; K B Elkon
Journal:  J Exp Med       Date:  1998-12-21       Impact factor: 14.307

View more
  228 in total

1.  Tag SNPs of CFI contributed to the susceptibility for non-small cell lung cancer in Chinese population.

Authors:  Yingwen Liu; Yanghui Bi; Jia Lin; Lei Cao; Bing He; Zhi Zhang; Yongping Cui; Xuemei Zhang
Journal:  Tumour Biol       Date:  2014-11-15

Review 2.  Multipotent mesenchymal stromal cells and the innate immune system.

Authors:  Katarina Le Blanc; Dimitrios Mougiakakos
Journal:  Nat Rev Immunol       Date:  2012-04-25       Impact factor: 53.106

Review 3.  Complement: a key system for immune surveillance and homeostasis.

Authors:  Daniel Ricklin; George Hajishengallis; Kun Yang; John D Lambris
Journal:  Nat Immunol       Date:  2010-08-19       Impact factor: 25.606

Review 4.  Targeted complement inhibition and microvasculature in transplants: a therapeutic perspective.

Authors:  M A Khan; J L Hsu; A M Assiri; D C Broering
Journal:  Clin Exp Immunol       Date:  2015-11-05       Impact factor: 4.330

Review 5.  Immune-mediated processes in neurodegeneration: where do we stand?

Authors:  Marc Fakhoury
Journal:  J Neurol       Date:  2016-02-12       Impact factor: 4.849

Review 6.  The complement system in COVID-19: friend and foe?

Authors:  Anuja Java; Anthony J Apicelli; M Kathryn Liszewski; Ariella Coler-Reilly; John P Atkinson; Alfred Hj Kim; Hrishikesh S Kulkarni
Journal:  JCI Insight       Date:  2020-08-06

7.  Complement inhibition alleviates paraquat-induced acute lung injury.

Authors:  Shihui Sun; Hanbin Wang; Guangyu Zhao; Yingbo An; Yan Guo; Lanying Du; Hongbin Song; Fei Qiao; Hong Yu; Xiaohong Wu; Carl Atkinson; Shibo Jiang; Stephen Tomlinson; Yusen Zhou
Journal:  Am J Respir Cell Mol Biol       Date:  2011-03-18       Impact factor: 6.914

8.  Plasmodium-infected erythrocytes induce secretion of IGFBP7 to form type II rosettes and escape phagocytosis.

Authors:  Wenn-Chyau Lee; Bruce Russell; Radoslaw Mikolaj Sobota; Khairunnisa Ghaffar; Shanshan W Howland; Zi Xin Wong; Alexander G Maier; Dominique Dorin-Semblat; Subhra Biswas; Benoit Gamain; Yee-Ling Lau; Benoit Malleret; Cindy Chu; François Nosten; Laurent Renia
Journal:  Elife       Date:  2020-02-18       Impact factor: 8.140

9.  Genetic and pharmacologic inhibition of complement impairs endothelial cell function and ablates ovarian cancer neovascularization.

Authors:  Selene Nunez-Cruz; Phyllis A Gimotty; Matthew W Guerra; Denise C Connolly; You-Qiang Wu; Robert A DeAngelis; John D Lambris; George Coukos; Nathalie Scholler
Journal:  Neoplasia       Date:  2012-11       Impact factor: 5.715

10.  Dynamic structural changes during complement C3 activation analyzed by hydrogen/deuterium exchange mass spectrometry.

Authors:  Michael C Schuster; Daniel Ricklin; Krisztián Papp; Kathleen S Molnar; Stephen J Coales; Yoshitomo Hamuro; Georgia Sfyroera; Hui Chen; Michael S Winters; John D Lambris
Journal:  Mol Immunol       Date:  2008-05-05       Impact factor: 4.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.